A medicine may show promise during development, but bringing it to commercial manufacturing presents a different challenge: can the same product quality be achieved consistently at a larger scale or a different manufacturing site? This is where pharmaceutical technology transfer plays a critical role. It connects scientific knowledge developed in the laboratory with the practical requirements of pharmaceutical manufacturing. From understanding formulation behaviour to establishing suitable process controls, a well-planned transfer helps teams prepare for reliable production. It is a crucial link between drug development and commercial readiness. [1]
Pharmaceutical technology transfer is the systematic process of transferring product and process knowledge from a development team to a manufacturing team, or between manufacturing sites. It ensures that the receiving team understands how to produce and test a medicine according to established quality requirements.
a medicine according to established quality requirements. This transfer involves more than sharing documents. It includes formulation details, manufacturing instructions, analytical testing methods, product specifications and quality controls. Both the sending unit, which provides the knowledge, and the receiving unit, which applies it, must work together to address technical differences and ensure the process can be performed consistently. [2]
Project Initiation - Identify the need for transfer and assess whether the receiving site has the necessary facilities, technology and expertise.
Project Planning - Define responsibilities, assess potential risks, review documentation and establish a transfer plan.
Transfer Execution - Transfer manufacturing knowledge and analytical procedures, carry out the planned activities, and document the results.
Project Review and Close-Out - Review the outcomes, check that planned activities have been completed and document the project's conclusion.
The exact activities depend on the product, process and transfer requirements. These phases provide a recognised framework rather than a fixed sequence that applies identically to every project. [3]
Transferring a manufacturing process to a new facility can present several technical and operational challenges. [4]
Facility and equipment differences: Variations in equipment capacity and processing conditions can affect manufacturing performance.
Documentation gaps: Incomplete manufacturing instructions or technical records can make the process difficult to reproduce.
Pharmaceutical process validation: Appropriate studies, sampling and data collection are needed to demonstrate consistent process performance.
Resource and timeline management: Equipment availability and testing requirements can delay manufacturing readiness.
Communication between teams: Poor coordination between development, manufacturing and quality teams can lead to misunderstandings and delays.
Early risk assessment, clear documentation and effective planning help manage these challenges and support a smoother technology transfer process.
During pharmaceutical technology transfer, companies must ensure that the receiving site can manufacture the medicine under appropriate quality controls. Three important areas need attention
The receiving site must have suitable equipment and facilities. EU GMP Annex 15 outlines expectations for equipment qualification and validation activities. [5]
Companies must collect appropriate evidence that the manufacturing process can consistently produce medicines meeting predefined quality requirements. The validation approach should reflect the process and its risks. [5]
If a transfer involves adding or changing a manufacturing site for an authorised medicine, regulatory requirements must be assessed. In the EU, such changes generally require a variation to the marketing authorisation; the UK follows its applicable MHRA procedures. [5]
Effective technology transfer helps pharmaceutical companies prepare for commercial manufacturing through:
For pharmaceutical companies seeking development and manufacturing partners, effective technology transfer supports better coordination and manufacturing readiness.
Successful pharmaceutical technology transfer depends on more than moving a product between sites. It requires technical knowledge, careful planning, effective collaboration and a clear focus on quality at every stage. As pharmaceutical companies prepare for commercial production, working with experienced development and manufacturing partners can help them navigate technical challenges and plan for manufacturing readiness. With its focus on pharmaceutical development, manufacturing and industry partnerships, Novumgen supports collaboration across the pharmaceutical value chain. The right expertise and a well-planned approach can help bridge the gap between drug development and commercial manufacturing.
Pharmaceutical technology transfer is the systematic transfer of product and process knowledge from a development team to a manufacturing team or between manufacturing sites. It includes formulation details, manufacturing instructions, analytical methods and quality requirements to support consistent production.
A pharmaceutical technology transfer project generally involves four phases: project initiation, project planning, transfer execution, and project review and close-out. The activities depend on the product, process, risks and requirements of the receiving site.
Process validation provides documented evidence that a manufacturing process can consistently produce products meeting predefined quality requirements. During technology transfer, appropriate validation activities help assess whether the process performs as intended at the receiving site.
Pharmaceutical technology transfer must consider applicable Good Manufacturing Practice (GMP) requirements, equipment qualification, process validation and documentation. Changes to manufacturing sites for authorised medicines may also require regulatory submissions, depending on the nature of the change and the applicable UK or EU procedure.
CDMO technology transfer enables pharmaceutical companies to share product and process knowledge with a Contract Development and Manufacturing Organisation (CDMO). Clear documentation, defined responsibilities and effective technical collaboration help support manufacturing scale-up, process understanding and quality consistency.